Camilla S.
- Country
- Sweden
- Department
- KFUE Blod och tumörsjukdomar, ingång 101, Akademiska Sjukhuset, Uppsala
Research Overview
- Phase III Study of AZD5335 Versus Mirvetuximab Soravtansine or Investigator's Choice Chemotherapy in Patients with FRα-High or FRα-Low Platinum-Resistant Epithelial Ovarian Cancer
- Evaluation of Safety and Tolerability of KAND567 and Carboplatin in Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Phase III Evaluation of Trastuzumab Deruxtecan with Rilvegostomig or Pembrolizumab versus Chemotherapy and Pembrolizumab in HER2-Expressing pMMR Endometrial Cancer
Data & Insights
Has run more than one trial at 66 of 175 partner sites.
Specializations
Gynecologic Oncology
The investigator specializes in treating complex gynecologic cancers, with particular focus on recurrent epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.
- Ovarian Cancer Management
- Peritoneal Malignancies
- Gynecologic Cancer Therapeutics
Their research interests encompass innovative therapeutic approaches for treating gynecologic malignancies.
Cancer Treatment Innovation
The investigator focuses on developing new therapeutic combinations for treating platinum-sensitive recurrent cancers. Their expertise includes evaluation of novel drug combinations with carboplatin therapy.
- Combination Therapy Development
- Treatment Optimization
- Drug Safety Assessment
Their work advances understanding of treatment options for patients with recurring gynecologic cancers.
Clinical Research
The investigator conducts research in therapeutic optimization for patients with recurring gynecologic cancers, particularly focusing on those who have undergone previous platinum-based treatments.
- Treatment Safety Evaluation
- Drug Tolerability Assessment
- Clinical Response Analysis
Their expertise extends to evaluating novel therapeutic approaches for patients with relapsed disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.